Technological innovation has changed the face of practically every industry. However, when it comes to matters of life and death, necessarily strict regulations have seen clinical trials lagging behind other lower risk industries which can put innovation into practice much more easily.
In Q2 of 2019 WBR Insights and Icertis surveyed 100 Clinical Operations Directors from pharmaceutical companies across Europe to find out more about the challenges they’re facing when implementing new technologies and digital processes in their clinical trials.